IDE196 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Protein Kinase C (PKC) Inhibitor

Filter by location:

Los Angeles, California1 trial

Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions

UCLA Medical Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.